|
dt1291
|
135413535
|
Valganciclovir
|
6565
|
SLC15A2
|
Homo sapiens (human)
|
10824137
|
--
|
Details
|
|
dt1292
|
135413535
|
Valganciclovir
|
11254
|
SLC6A14
|
Homo sapiens (human)
|
15290873
|
--
|
Details
|
|
dt1293
|
135413535
|
Valganciclovir
|
670
|
BPHL
|
Homo sapiens (human)
|
15832508
|
BPHL protein results in increased hydrolysis of valganciclovir
|
Details
|
|
dt1294
|
135413535
|
Valganciclovir
|
6564
|
SLC15A1
|
Homo sapiens (human)
|
10824137
|
SLC15A1 protein results in increased transport of valganciclovir|valganciclovir inhibits the reaction [SLC15A1 protein results in increased transport of glycylsarcosine]
|
Details
|
|
dt1295
|
135413535
|
Valganciclovir
|
6565
|
SLC15A2
|
Rattus norvegicus (Norway rat)
|
10824137
|
Valganciclovir inhibits the reaction [SLC15A2 protein results in increased transport of glycylsarcosine]
|
Details
|
|
dt1296
|
135413535
|
Valganciclovir
|
2703462
|
UL30
|
Human alphaherpesvirus 1 strain 17
|
--
|
Inhibitor
|
Details
|
|
dt1297
|
137441492
|
N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo[1(2H),2'-bipyridin]-3-yl)amino]-pyrazolo[1,5-a]pyrimidine-3-carboxamide
|
7297
|
TYK2
|
Homo sapiens (human)
|
--
|
Inhibition
|
Details
|
|
dt1298
|
137441492
|
N-[(1R,2R)-2-methoxycyclobutyl]-7-(methylamino)-5-[(2-oxo[1(2H),2'-bipyridin]-3-yl)amino]-pyrazolo[1,5-a]pyrimidine-3-carboxamide
|
7297
|
TYK2
|
Homo sapiens (human)
|
--
|
Inhibitor
|
Details
|
|
dt1299
|
139082353
|
Steroids
|
1576
|
CYP3A4
|
Homo sapiens (human)
|
15955870
|
Steroids results in increased expression of CYP3A4
|
Details
|
|
dt1300
|
139082353
|
Steroids
|
2554
|
GABRA1
|
Rattus norvegicus (Norway rat)
|
18275132
|
GABRA1 protein mutant form results in decreased susceptibility to steroids analog|steroids analog promotes the reaction [gamma-aminobutyric acid results in increased activity of [GABRA1 protein binds to GABRB2 protein binds to GABRG2 protein]]
|
Details
|